CHICAGO (AFP) -- An experimental vaccine designed to treat the most common and deadly brain tumor has more than doubled the survival of patients, according to results of a small clinical study.
 All Content by Mehr News Agency is licensed under a Creative Commons Attribution 4.0 International License.